Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SECUKINUMAB Cause Contraindicated product administered? 2,686 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 2,686 reports of Contraindicated product administered have been filed in association with SECUKINUMAB (COSENTYX). This represents 1.8% of all adverse event reports for SECUKINUMAB.

2,686
Reports of Contraindicated product administered with SECUKINUMAB
1.8%
of all SECUKINUMAB reports
1,142
Deaths
1,420
Hospitalizations

How Dangerous Is Contraindicated product administered From SECUKINUMAB?

Of the 2,686 reports, 1,142 (42.5%) resulted in death, 1,420 (52.9%) required hospitalization, and 1,395 (51.9%) were considered life-threatening.

Is Contraindicated product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 2,686 reports have been filed with the FAERS database.

What Other Side Effects Does SECUKINUMAB Cause?

Drug ineffective (27,434) Psoriasis (21,976) Pain (15,244) Arthralgia (13,769) Fatigue (9,406) Psoriatic arthropathy (8,900) Pruritus (8,755) Malaise (8,570) Rash (8,023) Condition aggravated (7,536)

What Other Drugs Cause Contraindicated product administered?

ABATACEPT (13,559) METHOTREXATE (13,121) ETANERCEPT (12,062) TOCILIZUMAB (11,547) ADALIMUMAB (11,270) LEFLUNOMIDE (11,206) HYDROXYCHLOROQUINE (10,557) RITUXIMAB (10,479) INFLIXIMAB (9,618) SULFASALAZINE (8,698)

Which SECUKINUMAB Alternatives Have Lower Contraindicated product administered Risk?

SECUKINUMAB vs SELADELPAR LYSINE SECUKINUMAB vs SELEGILINE SECUKINUMAB vs SELENIUM SECUKINUMAB vs SELENIUM SULFIDE SECUKINUMAB vs SELEXIPAG

Related Pages

SECUKINUMAB Full Profile All Contraindicated product administered Reports All Drugs Causing Contraindicated product administered SECUKINUMAB Demographics